ServiceNow Available For Sale Securities Debt Securities Current decreased by 3.0% to $2.48B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 23.2%, from $3.23B to $2.48B. Over 5 years (FY 2020 to FY 2025), Available For Sale Securities Debt Securities Current shows an upward trend with a 12.6% CAGR.
An increase suggests higher liquidity and a conservative cash management strategy, while a decrease may indicate cash deployment for operations or acquisitions.
This represents the portion of a company's investment portfolio consisting of debt securities that are expected to be so...
Common among large-cap pharmaceutical firms maintaining significant cash reserves for R&D and M&A activities.
current_assets_available_for_sale_securities_debt_securi_87ec82| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.62B | $1.63B | $1.58B | $1.76B | $2.17B | $2.71B | $2.81B | $3.06B | $3.08B | $2.96B | $2.98B | $3.05B | $3.25B | $3.41B | $3.46B | $3.23B | $3.01B | $2.69B | $2.56B | $2.48B |
| QoQ Change | — | +0.6% | -3.4% | +11.8% | +23.2% | +24.8% | +3.8% | +9.0% | +0.7% | -4.2% | +0.8% | +2.5% | +6.5% | +4.8% | +1.4% | -6.7% | -6.8% | -10.7% | -4.8% | -3.0% |
| YoY Change | — | — | — | — | +33.8% | +66.0% | +78.3% | +73.8% | +42.1% | +9.1% | +6.0% | -0.3% | +5.5% | +15.4% | +16.0% | +5.7% | -7.6% | -21.2% | -26.0% | -23.2% |